Patents Assigned to Gemini Laboratories, Inc.
  • ORAL LIQUID FORMULATIONS OF TACROLIMUS AND USES THEREOF
    Publication number: 20200297705
    Abstract: The present disclosure relates to oral liquid tacrolimus formulations and the use in treating organ or stem cell transplant recipients or T-cell mediated diseases.
    Type: Application
    Filed: March 10, 2020
    Publication date: September 24, 2020
    Applicant: Gemini Laboratories, Inc.
    Inventors: Hardik Patel, Amitkumar Patel, Suhaskumar Patel